Company intelligence / Profile preview

AviGenics

Athens, Georgia, United Statesavigenicsusa.com ↗

Ownership: Private
Development stage: Preclinical

Overview

AviGenics developed a proprietary avian transgenesis platform to produce recombinant therapeutic proteins in the eggs of genetically engineered chickens. Their lead clinical program, AVI 014 (a G-CSF analog), reached Phase 2 trials in breast cancer patients at risk of chemotherapy-induced neutropenia but was ultimately discontinued. The company also pursued preclinical programs focused on generating disease-resistant poultry using RNAi technology and producing other biotherapeutic proteins.[1][5]

Therapeutic areas: ImmunologyOtherOncologyRare DiseasesInfectious Diseases
Modalities: Recombinant proteinsRNA interference (RNAi)Transgenic avian bioreactors[1][2][3][4][7]
Industry: Biotech

Partnerships

No specific major pharmaceutical partnerships listed prior to acquisition; received venture funding from Stephens Group Inc., T.D. Javelin, Cordova Technology Partners, Kitty Hawk Capital, T.D. Lighthouse, Fuqua Ventures.[4] Later became part of Synageva/Alexion corporate structure.[8]

Beyond the preview

Go deeper on AviGenics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on AviGenics.

Explore the full profile